Current status of drug therapy for alveolar echinococcosis

doi:10.4254/wjh.v16.i11.1243

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-3) series.

Item

Count

PDF

HTML

Tables (1-3)

Sum=4

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=0

Publishing Process of This Article

Item

Count

Browse

Download

Sum=0

Nov 27, 2024 (publication date) through Nov 6, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Nov 27, 2024; 16(11): 1243-1254
Published online Nov 27, 2024. doi: 10.4254/wjh.v16.i11.1243

Table 1 The contents of the combination therapy with albendazole

Treatment plan	**In vitro or in vivo**	Treatment effect
ABZ + ubenimex	In vitro + in vivo	Better therapeutic effect
ABZ + carvacrol	In vitro + in vivo	Better therapeutic effect
ABZ + metformin	In vitro + in vivo	Better therapeutic effect
ABZ + atovaquone	In vitro + in vivo	Better therapeutic effect
ABZ + thymol	In vitro + in vivo	Better therapeutic effect
ABZ + 2-DG	In vitro	Better therapeutic effect
ABZ + nitazoxanide	In vitro	Has a certain effect
ABZ + GIZn	In vitro + in vivo	Has a certain effect
ABZ solubilizing agents	In vitro + in vivo	Better therapeutic effect

ABZ: Albendazole; 2-DG: 2-deoxy-D-glucose; GIZn: Glucan supplemented with zinc.

Citation: Jing QD, A JD, Liu LX, Fan HN. Current status of drug therapy for alveolar echinococcosis. World J Hepatol 2024; 16(11): 1243-1254
URL: https://www.wjgnet.com/1948-5182/full/v16/i11/1243.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i11.1243